Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24890763 | 0.82 | — | — | |
| SCHEMBL330763 | 0.80 | ACHE (0.33) | — | |
| SCHEMBL24593668 | 0.80 | APLNR (0.58) | APLNR | |
| SCHEMBL19164448 | 0.77 | — | — | |
| SCHEMBL22996976 | 0.75 | APLNR (0.35) | APLNR | |
| SCHEMBL18808086 | 0.73 | — | — | |
| SCHEMBL20412545 | 0.73 | — | — | |
| SCHEMBL20412544 | 0.73 | — | — | |
| SCHEMBL19164744 | 0.72 | — | — | |
| SCHEMBL18951183 | 0.72 | ACHE (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11111240-B2 | Sultam compound and application method thereof | Chai Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) | 2021-09-07 | — | — | US | disclosed |
| US-20210047314-A1 | Sultam Compound And Application Method Thereof | CENTAURUS BIOPHARMA CO., LTD. (CN) | 2021-02-18 | — | — | US | disclosed |
| EP-3434671-B1 | SULTAM COMPOUND AND APPLICATION METHOD THEREOF | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) | 2020-10-21 | — | — | EP | disclosed |
| WO-2017162157-A1 | SULTAM COMPOUND AND APPLICATION METHOD THEREOF | 正大天晴药业集团股份有限公司 | 2017-09-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11111240-B2 | Sultam compound and application method thereof | IDH1, IDH3A, IDH3B | APLNR 4770/4885 |
| US-20210047314-A1 | Sultam Compound And Application Method Thereof | IDH1, IDH3A, IDH3B | APLNR 4770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.